Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
96.95
-1.25 (-1.27%)
At close: Jan 30, 2026, 4:00 PM EST
97.90
+0.95 (0.98%)
After-hours: Jan 30, 2026, 7:56 PM EST
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $18.74 billion as of January 30, 2026. Its market cap has increased by 154.64% in one year.
Market Cap
18.74B
Enterprise Value
17.23B
1-Year Change
154.64%
Ranking
Category
Stock Price
$96.95
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $18.74B, an increase of 1,039.72%. That is a compound annual growth rate of 50.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 18.98B | 23.29% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 29.05B |
| Royalty Pharma | 23.82B |
| Genmab | 20.35B |
| Incyte | 19.56B |
| Moderna | 17.33B |
| Roivant Sciences | 15.10B |
| BridgeBio Pharma | 14.87B |
| Ascendis Pharma | 13.73B |